| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c58a362565a0616bcc3901fcbf9643de |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23e78a6d652e023b863b23acd43f99cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa9b8b346b746c2ce55ebc36bf32ddbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ae3409e79c6ad4b200aa5bf7fb70ca |
| publicationDate |
2013-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201347767-A |
| titleOfInvention |
Application of a Ganoderma lucidum extract component LZ-8 protein to inhibit cancer cell growth |
| abstract |
The present invention provides an application of the Ganoderma lucidum extract component to inhibit the growth of cancer cells, wherein the extract component is a Ling Zhi-8 (LZ-8) protein, which can prevent the ribosome pressure of the cancer cells, thereby preventing the murine in the cancer cells. The double minute 2 (MDM2) protein binds to the p53 protein, which in turn activates the p53 protein to inhibit the growth of cancer cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017080048-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9827288-B2 |
| priorityDate |
2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |